Company Filing History:
Years Active: 2010-2017
Title: Innovator Spotlight: Sylvia Limmer from Kulmbach, Germany
Introduction: Sylvia Limmer is a notable inventor based in Kulmbach, Germany, recognized for her significant contributions to the field of molecular biology. With a total of four patents to her name, her innovative work focuses on groundbreaking methods for inhibiting the expression of target genes. She is currently affiliated with Alnylam Pharmaceuticals, Inc., where she continues to advance her research.
Latest Patents: Sylvia's recent patents include compositions and methods that utilize double-stranded ribonucleic acid (dsRNA) to inhibit the expression of specific target genes. Her invention details a dsRNA sequence that is largely identical to a portion of the target gene, ranging in length from no more than 49 nucleotides, preferably under 25. This dsRNA features a complementary antisense RNA strand with a 1 to 4 nucleotide overhang at the 3'-end and a blunt 5′-end. Her pharmaceutical compositions, designed to be administered at low dosages, aim at effectively treating diseases linked to gene expression while ensuring safety and efficacy.
Career Highlights: Sylvia Limmer has established herself as an influential inventor in her field, with multiple patents that demonstrate her expertise and innovative spirit. Her work is instrumental in developing therapeutic solutions that have the potential to make a difference in patient care and disease treatment.
Collaborations: Throughout her career, Sylvia has had the opportunity to collaborate with a talented group of individuals, including her colleagues Roland Kreutzer and Stefan Limmer. These collaborations have enriched her research efforts and contributed to the successful development of her inventions.
Conclusion: Sylvia Limmer's contributions to the world of biotechnology are both impactful and inspiring. As an inventor with a keen focus on gene expression and its implications in healthcare, her work at Alnylam Pharmaceuticals exemplifies the spirit of innovation in modern science. With her ongoing research and dedication, she continues to pave the way for future advancements in the field.